Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
about
Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?The distinct traits of extracellular vesicles generated by transformed cells.Transglutaminase-2 promotes metastatic and stem-like phenotypes in osteosarcomaSelective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model
P2860
Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
@en
type
label
Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
@en
prefLabel
Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
@en
P2860
P1433
P1476
Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
@en
P2093
Kapil Mehta
Navneet Agnihotri
P2860
P2888
P304
P356
10.1007/S00726-016-2320-2
P577
2016-08-25T00:00:00Z